Awards as PI
| Funding | ||
|---|---|---|
| SEED Grant | Derivation and Characterization of Cancer Stem Cells from Human ES Cells | $642,500 |
| New Faculty II | Derivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells | $3,065,572 |
| Early Translational II | Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy | $3,341,758 |
Total: $7,049,830.00 |
Awards as Co-PI
| Disease Team Research I | Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) |
